Evonik Operations Gmbh

Monika Flügel

Richard Ducatelle

Filip Van Immerseel

Alexander Reth

Stefan Pelzer

Evy Goossens

Frank Thiemann

Sarah Hark

Florian Böhl

Bart Devreese

Griet Debyser

Lieven Van Meulebroek

Lynn Vanhaecke

Michelle Dargatz

Michaela Weissmann

Emeka Ignatius Igwe

Thomas Bekel

Emeka-Ignatius Igwe

Andreas Kappel

The invention pertains to an in vitro method for detecting avian intestinal dysbiosis, the method comprising determining the presence and/or level of isoleucyl-arginine (CHON) or isomers thereof in avian sample material wherein the presence and/or an increased level of isoleucyl-arginine (CHON) or isomers thereof in comparison to a non-affected control is indicative for avian intestinal dysbiosis.

In vitro method for detecting avian intestinal dysbiosis

The present invention pertains to an in vitro method for detecting intestinal barrier failure in an avian population, the method comprising the following steps: a) collecting a pooled fecal sample deriving from an avian population and b) determining the amount of at least one protein marker contained in said sample; wherein the at least one protein marker comprises or consists of an acute phase protein or a functional fragment thereof, and wherein an increased amount of said at least one protein marker contained in said sample versus a reference sample indicates intestinal barrier failure.

In vitro method for detecting intestinal barrier failure in animals

The present invention relates to a method for detectinginduced diseases in animals, the method comprising: a) collecting sample material of a specific animal or of a specific group of animals at consecutive points in time; b) determining the amount of a first marker and a second marker contained in the sample material; and c) determining the ratio of the first marker to the second marker contained in the sample material; wherein the first marker comprises a polynucleotide sequence being specific for thesub-species inducing the targeted disease; and the second marker comprises a polynucleotide being specific for the species; and wherein an increase in the ratio of the first marker to the second marker in the analyzed sample material over time is an indication of the targeted disease.

Method for detectinginduced diseases in animals

Growing community of inventors

Steinhagen, Germany

Monika Flügel